| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 396,4 k € | +7.6% | 368,5 k € | +20.2% | 306,6 k € | +7.3% | 285,7 k € | +18.2% | 241,7 k € | +0.7% | 239,9 k € | +5.9% | 226,6 k € | -0.0% | 226,6 k € | +5.7% | 214,4 k € | +16.5% | 184,1 k € | -5.6% | 194,9 k € | +132.1% | 84,0 k € | -60.8% | 214,5 k € | -2.1% | 219,2 k € | +8.5% | 202,0 k € | +0.3% | 201,5 k € | +7.4% | 187,6 k € | |
| EBITDA | 392,3 k € | +7.8% | 363,9 k € | +20.4% | 302,3 k € | +7.4% | 281,6 k € | +18.6% | 237,5 k € | +0.8% | 235,6 k € | +5.8% | 222,7 k € | +0.3% | 222,0 k € | +8.4% | 204,9 k € | +4.0% | 197,1 k € | +13.3% | 173,9 k € | +118.3% | 79,7 k € | -62.3% | 211,0 k € | -2.1% | 215,6 k € | +8.4% | 198,9 k € | +0.3% | 198,4 k € | +8.0% | 183,7 k € | |
| Operating profit | 371,0 k € | +7.5% | 345,1 k € | +24.5% | 277,2 k € | +8.8% | 254,9 k € | +24.8% | 204,2 k € | +2.5% | 199,2 k € | +4.3% | 191,0 k € | +5.7% | 180,7 k € | +7.8% | 167,7 k € | +21.7% | 137,8 k € | -1.3% | 139,7 k € | +198.8% | 46,8 k € | -74.0% | 180,1 k € | -2.4% | 184,5 k € | +5.4% | 175,0 k € | +1.1% | 173,1 k € | +9.3% | 158,4 k € | |
| Profit/loss | 278,0 k € | +22.5% | 227,0 k € | +26.1% | 180,0 k € | +6.4% | 169,2 k € | +16.4% | 145,3 k € | +5.4% | 137,9 k € | +5.7% | 130,5 k € | +18.1% | 110,5 k € | -3.5% | 114,5 k € | +45.0% | 78,9 k € | -14.6% | 92,4 k € | +103.1% | 45,5 k € | -65.4% | 131,6 k € | +3.3% | 127,4 k € | +0.8% | 126,4 k € | +5.9% | 119,4 k € | +3.9% | 114,9 k € | |
| Equity | 1,4 M € | +5.5% | 1,3 M € | -8.9% | 1,4 M € | +14.5% | 1,2 M € | +15.7% | 1,1 M € | +15.6% | 930,3 k € | +15.9% | 802,9 k € | -43.9% | 1,4 M € | +8.4% | 1,3 M € | +9.5% | 1,2 M € | +7.0% | 1,1 M € | +8.9% | 1,0 M € | -4.2% | 1,1 M € | +13.3% | 952,4 k € | +14.7% | 830,0 k € | +17.1% | 708,6 k € | +20.3% | 589,2 k € | |
| Total assets | 1,5 M € | +1.3% | 1,5 M € | -7.9% | 1,7 M € | -9.3% | 1,8 M € | +6.4% | 1,7 M € | +8.6% | 1,6 M € | +6.9% | 1,5 M € | -3.1% | 1,5 M € | +5.6% | 1,4 M € | +4.6% | 1,4 M € | +11.0% | 1,2 M € | -37.6% | 2,0 M € | +64.1% | 1,2 M € | +8.6% | 1,1 M € | +11.6% | 1,0 M € | +10.4% | 911,9 k € | +11.1% | 820,6 k € | |
| Cash | 155,8 k € | -43.6% | 276,5 k € | -42.0% | 476,4 k € | -28.2% | 663,3 k € | +11.2% | 596,2 k € | +11.9% | 532,9 k € | +16.9% | 456,0 k € | -3.1% | 470,4 k € | -24.8% | 625,2 k € | +10.0% | 568,3 k € | -35.1% | 875,2 k € | -1.9% | 892,4 k € | -1.0% | 901,1 k € | +17.2% | 768,5 k € | +11.0% | 692,7 k € | +160.9% | 265,5 k € | +75.7% | 151,1 k € | |
| Debts | 167,9 k € | -22.6% | 216,8 k € | -0.2% | 217,2 k € | -61.4% | 563,0 k € | -9.6% | 622,9 k € | -3.4% | 644,6 k € | -5.2% | 680,3 k € | +575.1% | 100,8 k € | -22.6% | 130,2 k € | -27.9% | 180,6 k € | +72.3% | 104,8 k € | -89.2% | 966,6 k € | +590.3% | 140,0 k € | -17.9% | 170,5 k € | -3.5% | 176,8 k € | -12.9% | 202,9 k € | -12.1% | 230,9 k € | |
Private limited company · Zoersel · incorporated on 18/09/1996
Private limited company profitable and well capitalised. Cash position declining (-43.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. VAN der WANGEN PETER is a Private limited company incorporated in 1996. Its main activity is: General medical practice activities. Its registered office is in Zoersel.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette